U.S. Tech Hardware Stock News

In February 2026, Raymond James Financial reported record fiscal Q1 revenue of US$3.70 billion, 6% higher year over year, while its board approved a quarterly dividend of US$0.54 per share payable on April 15 to shareholders of record on April 1. Behind the headlines, the firm’s emphasis on advisor-friendly policies with no mandated cross-selling, heavy investment in AI-driven technology, and robust client asset growth to US$1.71 trillion are increasingly shaping its competitive position in...

How the latest earnings reshaped the story around EXLS ExlService Holdings (EXLS) just reported fourth quarter and full year 2025 earnings, paired with fresh 2026 guidance and a new US$500 million buyback plan, giving investors several moving parts to consider. On top of that, recent client and product news shows how its data and AI focus is being put to work in real customer environments, which can matter when you think about the durability of the business model. See our latest analysis for...

Geopolitical tensions in the Middle East, higher oil prices, and extended U.S. export license reviews for AI hardware have recently pressured semiconductor stocks, putting Nova (NasdaqGS:NVMI) back on many investors’ watchlists. See our latest analysis for Nova. Despite the recent pullback linked to geopolitical headlines and AI export uncertainties, Nova’s 90 day share price return of 37.77% and 1 year total shareholder return of 94.26% suggest momentum has been building rather than...

Sarepta Therapeutics (SRPT) is back in focus after recent analyst commentary framed the company as a potential recovery story, highlighting Elevidys launch efforts, upcoming FDA discussions on PMO therapies, and fresh detail from its latest 10-K. See our latest analysis for Sarepta Therapeutics. Sarepta’s recent CEO retirement plans, weaker Q4 2025 results and the Elevidys launch in Japan have played out against a tougher price backdrop. A 30 day share price return of 22.35% and a 1 year...

Mohawk Industries’ recent inclusion in the S&P 500 Index marks a major step for the global flooring manufacturer, which serves residential and commercial markets across multiple regions. This index addition comes despite muted long-term revenue expansion and a declining return on invested capital, highlighting a contrast between market prominence and operational headwinds. Next, we’ll examine how Mohawk’s entry into the S&P 500 could reshape its investment narrative, including expectations...

Madrigal Pharmaceuticals: recent performance in focus Madrigal Pharmaceuticals (MDGL) has drawn investor attention after recent share price moves, with the stock up about 0.2% over the past day but showing declines over the past month and the past three months. See our latest analysis for Madrigal Pharmaceuticals. At a share price of US$434.80, Madrigal Pharmaceuticals has seen recent momentum fade, with a 30 day share price return of an 11.22% decline and a year to date share price return of...

Why CoreWeave is on investors’ radar CoreWeave (CRWV) has drawn fresh attention after a 7.8% gain over the past day, contrasting with weaker recent returns over the month and past 3 months and prompting a closer look at its fundamentals. See our latest analysis for CoreWeave. That 7.8% 1 day share price return comes after weaker short term performance, with the 7 day and 30 day share price returns of 18.9% and 10.6% declines respectively. This suggests momentum has been fading recently...

Peabody Energy Corporation recently presented at the 35th BMO Global Metals, Mining & Critical Minerals Conference in Hollywood, Florida, highlighting its role in global coal markets. At the same time, geopolitical tensions and strikes on Iran have lifted coal prices by avoiding direct supply disruption, improving sentiment toward coal-focused companies such as Peabody. We will now examine how heightened coal prices amid geopolitical risk could influence Peabody Energy’s existing investment...

Key financial snapshot for TJX Companies (TJX) TJX Companies (TJX) closed at $161.73, with revenue of about $60.4b and net income of roughly $5.5b. This gives investors a sense of the retailer’s current earnings scale. Recent share performance shows a 1 day return of 1.3%, a 7 day return of 3.8%, and about 7.7% over the past month and past 3 months, with a 4.8% year to date move and a 33% total return over the past year. Looking further back, total returns over the past 3 years and 5 years...

Choice Hotels International (CHH) has been in focus after reporting fourth quarter and full year 2025 results, issuing 2026 net income guidance, and affirming its regular quarterly cash dividend. See our latest analysis for Choice Hotels International. The share price has moved to US$104.46 after an 18.9% 90-day share price return and an 8.7% year-to-date share price return. However, the 1-year total shareholder return of a 26.8% decline indicates that longer term momentum has been weaker...

GRAIL, Inc. recently reported fourth-quarter and full-year 2025 results, showing higher sales and revenue alongside continued net losses, and released topline data from the large NHS-Galleri trial in England evaluating its Galleri multi-cancer blood test in a real-world screening setting. Although the NHS-Galleri trial did not meet its primary endpoint of statistically significant Stage III–IV cancer reduction, it indicated meaningful shifts toward earlier-stage detection and fewer emergency...

What PG&E’s latest rate cut could mean for shareholders PG&E (PCG) cut residential bundled electric rates again on March 1, 2026, its third consecutive reduction since last September and part of a cumulative 13% decrease versus January 2024. For investors, this pricing move sits alongside PG&E Corporation’s declared first quarter 2026 regular cash dividend of $0.05 per share, payable on April 15, 2026, to shareholders of record on March 31, 2026. See our latest analysis for PG&E. Against this...

Littelfuse stock snapshot Littelfuse (LFUS) has drawn attention after recent trading left the shares about 2% lower on the day and roughly 10% lower over the past week, despite solid multi period total returns. See our latest analysis for Littelfuse. Despite the recent 10.3% 7 day share price decline, Littelfuse’s 30.5% 90 day share price return and 57.1% 1 year total shareholder return suggest longer term momentum has been stronger than the latest pullback implies. If this kind of move has...

MillerKnoll recently reported quarterly results showing revenue slightly lower than a year earlier, yet both earnings and sales exceeded analyst expectations. The company also issued next‑quarter earnings and revenue guidance above consensus forecasts, underscoring management’s confidence in its near‑term operating outlook. Now we’ll consider how MillerKnoll’s stronger‑than‑expected guidance may influence its previously discussed investment narrative and future performance expectations. The...

In recent weeks, Ensign Group has continued its run of quarterly earnings beats, with the latest report exceeding profit expectations even as revenue landed slightly below forecasts. Analysts now expect further earnings and revenue expansion, reinforcing an investment narrative grounded in consistent operational execution rather than recent insider filings, which showed no meaningful share activity. Next, we’ll examine how Ensign Group’s ongoing earnings outperformance shapes its broader...

If you are wondering whether American Homes 4 Rent is offering good value at its current price, you are not alone. This article will walk through what the numbers actually say about the stock. The shares last closed at US$30.03, with returns of 0.7% over 7 days, a 2.5% decline over 30 days, and negative returns of 5.9% year to date and 15.5% over 1 year, but positive 6.0% over 3 years and 10.3% over 5 years. Recent moves in American Homes 4 Rent have come as investors continue to assess the...

PACS Group (PACS) shares fell after the company paired record 2025 results with new 2026 guidance and a slight revenue shortfall to expectations, prompting investors to reassess how much of its growth story is already priced in. See our latest analysis for PACS Group. At a share price of US$36.35, PACS Group has given investors a 174% 1 year total shareholder return. This comes as recent earnings news and 2026 guidance coincided with a 7 day share price return of 8% and a softer 1 day share...

In late February 2026, Autodesk reported fourth-quarter revenue of US$1,957 million and net income of US$316 million, with full-year revenue reaching US$7.21 billion and net income of US$1.12 billion, and issued new guidance for fiscal 2027 revenue of US$8.10–8.17 billion and GAAP EPS of US$7.76–8.39. Alongside these results, Autodesk highlighted AI-powered design tools and cloud platforms such as Fusion and Construction Cloud, underpinned by a new collaboration with BioDapt to develop...

Eli Lilly (NYSE:LLY) has entered a $1 billion AI-focused drug discovery partnership with Nvidia, aimed at using advanced computing to support pharmaceutical R&D. The company received a positive opinion from the EMA for Olumiant in adolescents with severe alopecia areata. Phase 3 results for its oral GLP-1 candidate orforglipron were reported as promising, adding to its metabolic pipeline. The FDA approved a new label for Zepbound, broadening Eli Lilly's weight loss therapy offering. For...

HSBC’s recent upgrade of QuantumScape (QS) to Hold, tied to the company hitting its 2025 goals and progressing on solid state battery commercialization, has put fresh attention on the stock’s long term thesis. See our latest analysis for QuantumScape. Even with HSBC’s upgrade and progress on solid state batteries across autos, robotics and data centers, QuantumScape’s share price has been volatile. A 1 day share price return of 7.03% contrasts with a 30 day share price return decline of...

GeneDx Holdings Corp. recently reported full-year 2025 results showing revenue of US$427.54 million and a narrower net loss of US$21.02 million, reaffirmed its 2026 revenue guidance of US$540 million to US$555 million, and filed a US$143.99 million shelf registration for employee stock plans. Shortly after, the company entered into a new US$100 million term loan with Blackstone affiliates, refinancing its prior credit facility and extending its debt maturity to February 27, 2031, which could...

Walker & Dunlop, Inc. recently hired Mark Washington as managing director of Capital Markets, Multifamily Investment Sales, to lead its entry into Pacific Northwest multifamily investment sales from a new base in Seattle. By adding an institutional broker involved in over US$50.00 billion of capital markets transactions, Walker & Dunlop is deepening its access to one of the country’s most actively traded multifamily regions. Next, we’ll examine how this expansion into Pacific Northwest...

Elevance Health (NYSE:ELV) is facing potential sanctions from the Centers for Medicare & Medicaid Services that could suspend new enrollment and restrict certain communications for its Medicare Advantage plans due to alleged noncompliance with risk adjustment data submission rules. The company also launched a national pilot program with the National Diaper Bank Network that will provide diaper support to families as part of a broader effort to address maternal and child health outcomes. For...

DXC Technology recently outlined its renewed vision at the Morgan Stanley Technology, Media & Telecom Conference 2026, emphasizing a dual-track plan to upgrade core IT services and develop AI-enhanced offerings, including a refreshed Hogan core banking platform and a more modular approach to client solutions. The company also highlighted disciplined operational changes, such as exiting lower-margin work, streamlining its workforce, and favoring organic growth and acqui-hires over large...